Nevertheless, although the role of the apelinergic system during tumor progression and blood vessel formation has been an emerging focus of cancer and vascular research in recent years, whether and how apelin/APJ signaling contributes to tumor-induced lymphangiogenesis and lymphatic metastasis remains unclear. Here, APLN is linked to cancer.